The future belongs to those who believe in multiplex CAR T engineering
Cell Stem Cell · 2025-07 · 32 (7) · 1031-1033
DOI: 10.1016/j.stem.2025.06.008 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell Stem Cell, 2025-07. Verfasst von Laura Volta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Immunotherapy, Adoptive, T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Swiss National Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
- Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland. Electronic address: chiara.magnani@usz.ch.
Förderung
- Swiss National Science Foundation
Zitieren
APA
Volta, L., & Magnani, C. F. (2025). The future belongs to those who believe in multiplex CAR T engineering. Cell Stem Cell, 32(7), 1031-1033. https://doi.org/10.1016/j.stem.2025.06.008
Vancouver
Volta L, Magnani CF. The future belongs to those who believe in multiplex CAR T engineering. Cell Stem Cell. 2025;32(7):1031-1033. doi:10.1016/j.stem.2025.06.008
BibTeX
@article{Volta2025,
author = {Volta, Laura and Magnani, Chiara F},
title = {The future belongs to those who believe in multiplex CAR T engineering},
journal = {Cell Stem Cell},
year = {2025},
volume = {32},
number = {7},
pages = {1031--1033},
doi = {10.1016/j.stem.2025.06.008}
}
EUVIMED